More

• About Us (main page)

• Executive Director

• Board of Directors

Charles Eggert
President and Chief Executive Officer, OpX Biotechnologies

Charles Eggert joined OpX Biotechnologies as president and chief executive officer in September 2008. At OpX he is applying more than 30 years of experience in the global specialty chemical industry to the commercialization of biorefined fuels and chemicals from renewable resources using the OpX EDGE (TM) technology for metabolic engineering.

Prior to joining OpX, Eggert was president of the specialty polymers group, a $500 million revenue division of Akzo Nobel. The group was responsible for innovating and supplying natural and synthetic polymers to a broad range of industrial and consumer product customers. Earlier, he held top management responsibility for the food ingredients - Europe and global personal care business units of ICI/National Starch and Chemical Company prior to the acquisition of ICI by Akzo Nobel. While at ICI, he was a board director of the American Chemistry Council.

Eggert began his career with Monsanto Co., progressing through roles in technology, manufacturing, business development, marketing, and general management with increasing responsibilities. His work at Monsanto included an assignment as vice president of Monsanto Venture Capital.

Eggert earned a Master of Business Administration degree in marketing and finance from Washington University in St. Louis and a Master of Science degree in biochemical engineering from the University of Minnesota. He also holds a Bachelor of Science degree in chemical engineering from Washington University.